Filing Details

Accession Number:
0001689375-23-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-19 17:27:51
Reporting Period:
2023-10-17
Accepted Time:
2023-10-19 17:27:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689375 Entrada Therapeutics Inc. TRDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1613084 Dipal Doshi C/O Entrada Therapeutics, Inc.
One Design Center Place, Suite 17-500
Boston MA 02210
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-10-17 1,000 $15.00 247,279 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.